Morningstar Investment Services LLC Biogen Inc. Transaction History

Morningstar Investment Services LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $34,674 - $43,083	-182 Reduced 12.75%	1,245 $285,000
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $90,956 - $114,847	-429 Reduced 23.11%	1,427 $309,000
Q4 2023 Feb 13, 2024	BUY	$222.59 - $267.94 $227,709 - $274,102	1,023 Added 122.81%	1,856 $484,000
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $10,638 - $12,007	-42 Reduced 4.8%	833 $215,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $240,843 - $278,302	875 New	875 $247,000
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $117,962 - $140,279	-629 Reduced 4.44%	13,537 $2.78 Million
Q4 2021 Feb 01, 2022	BUY	$223.92 - $287.77 $699,750 - $899,281	3,125 Added 28.3%	14,166 $3.4 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $512,211 - $667,980	1,810 Added 19.61%	11,041 $3.15 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $4.07 Million - $6.52 Million	-15,729 Reduced 63.02%	9,231 $3.19 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $103,481 - $155,765	-438 Reduced 1.72%	24,960 $6.11 Million
Q2 2020 Jul 30, 2020	BUY	$258.66 - $342.55 $6.57 Million - $8.7 Million	25,398 New	25,398 $6.61 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $6.22 Million - $6.97 Million	-28,597 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $1.04 Million - $1.15 Million	-4,744 Reduced 14.23%	28,597 $6.69 Million
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $7.23 Million - $11.3 Million	33,341 New	33,341 $7.88 Million

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Morningstar Investment Services LLC, based on Form 13F filings with the SEC.

Stay updated on Morningstar Investment Services LLC with notifications on news.